• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆性造血中的反复缺失是由微同源介导的末端连接驱动的。

Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.

机构信息

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Nat Commun. 2021 Apr 28;12(1):2455. doi: 10.1038/s41467-021-22803-y.

DOI:10.1038/s41467-021-22803-y
PMID:33911081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8080710/
Abstract

The mutational mechanisms underlying recurrent deletions in clonal hematopoiesis are not entirely clear. In the current study we inspect the genomic regions around recurrent deletions in myeloid malignancies, and identify microhomology-based signatures in CALR, ASXL1 and SRSF2 loci. We demonstrate that these deletions are the result of double stand break repair by a PARP1 dependent microhomology-mediated end joining (MMEJ) pathway. Importantly, we provide evidence that these recurrent deletions originate in pre-leukemic stem cells. While DNA polymerase theta (POLQ) is considered a key component in MMEJ repair, we provide evidence that pre-leukemic MMEJ (preL-MMEJ) deletions can be generated in POLQ knockout cells. In contrast, aphidicolin (an inhibitor of replicative polymerases and replication) treatment resulted in a significant reduction in preL-MMEJ. Altogether, our data indicate an association between POLQ independent MMEJ and clonal hematopoiesis and elucidate mutational mechanisms involved in the very first steps of leukemia evolution.

摘要

克隆性造血中反复缺失的突变机制尚不完全清楚。在本研究中,我们检查了髓系恶性肿瘤中反复缺失的基因组区域,并在 CALR、ASXL1 和 SRSF2 基因座中鉴定出基于微同源性的特征。我们证明这些缺失是 PARP1 依赖性微同源介导末端连接(MMEJ)途径双链断裂修复的结果。重要的是,我们提供的证据表明这些反复缺失起源于白血病前干细胞。虽然 DNA 聚合酶θ(POLQ)被认为是 MMEJ 修复的关键组成部分,但我们提供的证据表明,白血病前 MMEJ(preL-MMEJ)缺失可以在 POLQ 敲除细胞中产生。相比之下,阿非迪可林(一种复制聚合酶和复制抑制剂)处理导致 preL-MMEJ 显著减少。总之,我们的数据表明 POLQ 独立的 MMEJ 与克隆性造血之间存在关联,并阐明了白血病进化最初步骤中涉及的突变机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/819d44e51ea8/41467_2021_22803_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/1b9de936f52d/41467_2021_22803_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/1fba0262c858/41467_2021_22803_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/f15dfffb08c4/41467_2021_22803_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/901ae9a8821e/41467_2021_22803_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/0f702d6d2511/41467_2021_22803_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/b5f59b639143/41467_2021_22803_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/6e02442449ae/41467_2021_22803_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/819d44e51ea8/41467_2021_22803_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/1b9de936f52d/41467_2021_22803_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/1fba0262c858/41467_2021_22803_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/f15dfffb08c4/41467_2021_22803_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/901ae9a8821e/41467_2021_22803_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/0f702d6d2511/41467_2021_22803_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/b5f59b639143/41467_2021_22803_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/6e02442449ae/41467_2021_22803_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8080710/819d44e51ea8/41467_2021_22803_Fig8_HTML.jpg

相似文献

1
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.克隆性造血中的反复缺失是由微同源介导的末端连接驱动的。
Nat Commun. 2021 Apr 28;12(1):2455. doi: 10.1038/s41467-021-22803-y.
2
A role for human homologous recombination factors in suppressing microhomology-mediated end joining.人类同源重组因子在抑制微同源性介导的末端连接中的作用。
Nucleic Acids Res. 2016 Jul 8;44(12):5743-57. doi: 10.1093/nar/gkw326. Epub 2016 Apr 29.
3
Polymerase theta is a synthetic lethal target for killing Epstein-Barr virus lymphomas.聚酶 theta 是一种合成致死靶点,可用于杀死爱泼斯坦-巴尔病毒淋巴瘤。
J Virol. 2024 Jul 23;98(7):e0057224. doi: 10.1128/jvi.00572-24. Epub 2024 Jun 11.
4
DNA polymerase θ (POLQ), double-strand break repair, and cancer.DNA聚合酶θ(POLQ)、双链断裂修复与癌症
DNA Repair (Amst). 2016 Aug;44:22-32. doi: 10.1016/j.dnarep.2016.05.003. Epub 2016 May 14.
5
Microhomology Selection for Microhomology Mediated End Joining in .Microhomology 选择用于. 中的 Microhomology 介导末端连接
Genes (Basel). 2019 Apr 8;10(4):284. doi: 10.3390/genes10040284.
6
Assays for DNA double-strand break repair by microhomology-based end-joining repair mechanisms.基于微同源性的末端连接修复机制对DNA双链断裂修复的检测。
Nucleic Acids Res. 2016 Apr 7;44(6):e56. doi: 10.1093/nar/gkv1349. Epub 2015 Dec 10.
7
Plant organellar DNA polymerases repair double-stranded breaks by microhomology-mediated end-joining.植物细胞器 DNA 聚合酶通过微同源介导的末端连接修复双链断裂。
Nucleic Acids Res. 2019 Apr 8;47(6):3028-3044. doi: 10.1093/nar/gkz039.
8
Homology and enzymatic requirements of microhomology-dependent alternative end joining.微同源性依赖的替代末端连接的同源性和酶促要求。
Cell Death Dis. 2015 Mar 19;6(3):e1697. doi: 10.1038/cddis.2015.58.
9
Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ.人DNA聚合酶θ促进的微同源性介导的末端连接机制。
Nat Struct Mol Biol. 2015 Mar;22(3):230-7. doi: 10.1038/nsmb.2961. Epub 2015 Feb 2.
10
Microhomology-Mediated End-Joining Chronicles: Tracing the Evolutionary Footprints of Genome Protection.微同源介导的末端连接编年史:追踪基因组保护的进化足迹。
Annu Rev Cell Dev Biol. 2024 Oct;40(1):195-218. doi: 10.1146/annurev-cellbio-111822-014426. Epub 2024 Sep 21.

引用本文的文献

1
Clonal hematopoiesis in myeloid malignancies and solid tumors.髓系恶性肿瘤和实体瘤中的克隆性造血
Nat Cancer. 2025 Jul 18. doi: 10.1038/s43018-025-01014-0.
2
Refined DNA repair manipulation enables a universal knock-in strategy in mouse embryos.优化的DNA修复操作可实现小鼠胚胎中的通用敲入策略。
Nat Commun. 2025 Jul 15;16(1):6502. doi: 10.1038/s41467-025-61696-z.
3
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders.克隆性造血在血液系统和非血液系统疾病中的意义

本文引用的文献

1
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
2
MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions.MetaCell:基于 K-近邻图分区的单细胞 RNA-seq 数据分析。
Genome Biol. 2019 Oct 11;20(1):206. doi: 10.1186/s13059-019-1812-2.
3
Molecular basis of microhomology-mediated end-joining by purified full-length Polθ.全长 Polθ 通过纯酶介导的微同源末端连接的分子基础。
Cancers (Basel). 2024 Dec 9;16(23):4118. doi: 10.3390/cancers16234118.
4
Utilizing insights of DNA repair machinery to discover MMEJ deletions and novel mechanisms.利用DNA修复机制的见解来发现微同源性介导的末端连接缺失和新机制。
Nucleic Acids Res. 2024 Dec 11;52(22):e106. doi: 10.1093/nar/gkae1132.
5
The Role of Mutated Calreticulin in the Pathogenesis of -Negative Myeloproliferative Neoplasms.突变钙网织蛋白在 - 阴性骨髓增殖性肿瘤发病机制中的作用。
Int J Mol Sci. 2024 Sep 12;25(18):9873. doi: 10.3390/ijms25189873.
6
Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies.富含丝氨酸/精氨酸的剪接因子在造血作用及造血系统恶性肿瘤中的功能
Cancer Cell Int. 2024 Jul 21;24(1):257. doi: 10.1186/s12935-024-03438-7.
7
Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands.造血干细胞的演变:一生适应机体需求。
Cell Stem Cell. 2023 Nov 2;30(11):1403-1420. doi: 10.1016/j.stem.2023.09.013. Epub 2023 Oct 20.
8
Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.同时靶向 DNA 聚合酶 θ 和 PARP1 或 RAD52 可在同源重组缺陷性白血病细胞中引发双重合成致死。
Mol Cancer Res. 2023 Oct 2;21(10):1017-1022. doi: 10.1158/1541-7786.MCR-22-1035.
9
Multifaceted Nature of DNA Polymerase θ.DNA聚合酶θ的多面性
Int J Mol Sci. 2023 Feb 10;24(4):3619. doi: 10.3390/ijms24043619.
10
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.DNA 聚合酶 θ 保护白血病细胞免受代谢诱导的 DNA 损伤。
Blood. 2023 May 11;141(19):2372-2389. doi: 10.1182/blood.2022018428.
Nat Commun. 2019 Sep 27;10(1):4423. doi: 10.1038/s41467-019-12272-9.
4
Precise therapeutic gene correction by a simple nuclease-induced double-stranded break.通过简单的核酸酶诱导的双链断裂实现精确的治疗性基因校正。
Nature. 2019 Apr;568(7753):561-565. doi: 10.1038/s41586-019-1076-8. Epub 2019 Apr 3.
5
Functional genomic landscape of acute myeloid leukaemia.急性髓系白血病的功能基因组图谱。
Nature. 2018 Oct;562(7728):526-531. doi: 10.1038/s41586-018-0623-z. Epub 2018 Oct 17.
6
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.骨髓增殖性肿瘤的分类与个体化预后
N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.
7
Population dynamics of normal human blood inferred from somatic mutations.从体细胞突变推断正常人体血液的种群动态。
Nature. 2018 Sep;561(7724):473-478. doi: 10.1038/s41586-018-0497-0. Epub 2018 Sep 5.
8
Decoding non-random mutational signatures at Cas9 targeted sites.解码 Cas9 靶向位点的非随机突变特征。
Nucleic Acids Res. 2018 Sep 19;46(16):8417-8434. doi: 10.1093/nar/gky653.
9
Prediction of acute myeloid leukaemia risk in healthy individuals.预测健康个体中的急性髓系白血病风险。
Nature. 2018 Jul;559(7714):400-404. doi: 10.1038/s41586-018-0317-6. Epub 2018 Jul 9.
10
Minimap2: pairwise alignment for nucleotide sequences.Minimap2:核苷酸序列的两两比对。
Bioinformatics. 2018 Sep 15;34(18):3094-3100. doi: 10.1093/bioinformatics/bty191.